Oneview one project at a time
Chris Stott
Portfolio Manager
On Monday, ASX-listed Irish healthcare company Oneview Healthcare Limited (ASX: ONE) announced a pilot project to measure the impact of a new electronic patient care pathway for prostate cancer patients. The collaborative project, with partners including the University of Oxford, is expected to commence in March 2017. The company said the project may lead to commercialisation opportunities. We believe Oneview will continue to gain market share both domestically and globally through capitalising on their innovative and superior product suite. Shares in Oneview closed flat for the week. We own Oneview as a research-driven investment in WAM Capital and WAM Research.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Chris was the Chief Investment Officer of Wilson Asset Management, having joined the company in 2006. He was also the Portfolio Manager responsible for WAM Capital (ASX:WAM), WAM Research (ASX:WAX), WAM Active (ASX:WAA) and WAM MicroCap (ASX:WMI).
2 stocks mentioned
Chris Stott
Portfolio Manager
Chris was the Chief Investment Officer of Wilson Asset Management, having joined the company in 2006. He was also the Portfolio Manager responsible for WAM Capital (ASX:WAM), WAM Research (ASX:WAX), WAM Active (ASX:WAA) and WAM MicroCap (ASX:WMI).
Chris Stott
Portfolio Manager
Chris was the Chief Investment Officer of Wilson Asset Management, having joined the company in 2006. He was also the Portfolio Manager responsible for WAM Capital (ASX:WAM), WAM Research (ASX:WAX), WAM Active (ASX:WAA) and WAM MicroCap (ASX:WMI).
Comments
Comments
Sign In or Join Free to comment